Zogenix Inc (USD)
ZGNX
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 28.59 | 29.98 |
| 52-Wk Range | - | - |
| Last Close | - |
| Mkt Cap (m) | - |
| Dividend yield | - |
| ISIN | US98978L2043 |
| Volume | 829,643.00 |
| Exchange Venue | NAS |
Company Profile
Zogenix Inc is a pharmaceutical company engaged in commercializing and developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.
Key Information
| Price/Earning | - |
| Price/Book | - |
| Price/Sales | - |
| P/CF | - |
| Rev Growth (3 year avg) | -49.81 |
| EPS Growth (3 year avg) | - |
| Operating Margin % | -11,628.87 |
| Net Margin % | -11,499.53 |
| Return on Equity | -109.27 |
| Debt/Equity | 0.05 |
Documents
Prospectus
| en 04/03/2020 |
Annual Report
| en 31/12/2019 |
Please refer to the below issuer website for further documents.
Financials
Income Statement
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Revenue (m) | 40.53 | 27.18 | 28.85 | 9.82 | 0.00 | 3.65 |
| Operating Income (m) | -99.18 | -49.73 | -62.45 | -94.24 | -139.88 | -424.22 |
| Net Income (m) | 8.59 | 26.14 | -69.71 | -126.82 | -123.91 | -419.50 |
| Basic EPS | 0.48 | 1.22 | -2.81 | -4.65 | -3.27 | -9.74 |
| Avg. Diluted Shares Outstanding (m) | 18.13 | 21.45 | 24.79 | 27.30 | 37.88 | 43.08 |
Balance Sheet
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Current Assets (m) | 77.98 | 184.60 | 119.91 | 304.70 | 532.73 | 287.24 |
| Non Current Assets (m) | 124.86 | 121.39 | 111.59 | 112.91 | 115.60 | 127.01 |
| Total Assets (m) | 202.84 | 305.99 | 231.51 | 417.61 | 648.33 | 414.25 |
| Current Liabilities (m) | 44.24 | 30.08 | 20.31 | 20.98 | 58.38 | 95.39 |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 55.28 | 182.76 | 120.76 | 301.52 | 522.80 | 245.06 |
Cash Flows
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Operating Cash Flows (m) | -80.82 | -64.60 | -72.88 | -75.87 | -111.66 | -111.52 |
| Capital Expenditure (m) | -0.12 | -0.31 | -0.10 | -0.08 | -1.02 | -9.49 |
Figures are quoted in USD unless stated otherwise
$
29.19
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.